重新设计miR-34a:miRNA抗癌剂的治疗开发中的结构和化学进展
Shreyas G Iyer1,2, Ikjot S Sohal1,3, Andrea L Kasinski1,3
1Department of Biological Sciences, Purdue University, West Lafayette IN, 47907, U.S.A.
Biochemical Society transactions
|August 4, 2025
概括
化学修饰的微RNAs (miRNAs) 通过向多个基因,显示出癌症治疗的前景. 修改增强稳定性和输送,导致显著的体内抗癌活性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 通过同时下调多个基因,为癌症提供治疗潜力.
- 癌症的异质性需要能够解决多样化的分子途径的疗法.
- 与原生miRNAs面临的挑战包括核酶敏感性,免疫性和剂量要求.
研究的目的:
- 审查提高miRNA稳定性和针对癌症治疗的向输送的化学修改.
- 突出完全修改的miRNAs (FM-miRNAs) 在临床前环境中的发展和意义.
主要方法:
- 分析了miRNA核糖 (例如2'-O-甲基,2'-) 和骨干 (例如酸) 的化学修饰.
- 讨论了针对瘤的特定输送的联结体向策略.
- 介绍了第一个完全修改的miR-34a (FM-miR-34a) 的开发.
主要成果:
- 核糖和骨干修改改善了核酶抵抗力,血稳定性,并降低了免疫性.
- 酸骨干的修改增强了血清蛋白的亲和力和循环时间.
- 干向促进了瘤特异性传递,改善了透,并克服了内分体捕获.
- FM-miR-34a在体内表现出相当大的抗癌活性.
结论:
- 化学修饰的miRNAs代表了癌症等复杂疾病的可行的治疗策略.
- 优化化学修饰和连接体化学,潜在的AI辅助,将推进基于miRNA的治疗方法.
- 作为下一代抗癌剂,FM-miRNA具有显著的前景.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Mitogens and the Cell Cycle
6.8K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


